-
Sponsored by Tilleke & GibbinsWong Vorravitwattana and Nuttaphol Arammuang of Tilleke & Gibbins analyse a Thai court ruling that shows how trademark claims and interim relief can strengthen franchisor protection against post-termination operations -
Sponsored by CASCAS provides practical pointers on how intellectual property and R&D teams can work in tandem to unlock tangible benefits and avoid wasted spend
-
Sponsored by CASCAS explores how AI is transforming intellectual property, from inventorship and copyright disputes to new demands on patent attorneys
-
Sponsored by That.LegalGillian Tan of That.Legal discusses a recent decision by the Intellectual Property Office of Singapore and what it reveals about the evidential burden in bad-faith trademark claims
-
Sponsored by Licks AttorneysEduardo Hallak, Rafaella Oliveira, and Laís Souza of Licks Attorneys explain how the provision operates in practice, highlighting evidential hurdles and best practices for patent applicants
-
Sponsored by Liu, Shen & AssociatesChunyu Cui and Ziqing Wu of Liu, Shen & Associates say recent trends in China’s intellectual property courts indicate alignment with international standards and send a clear signal to the global market
-
Sponsored by Cabinet M OproiuRaluca Vasilescu of Cabinet M Oproiu considers how the use of AI assistants may influence clients’ general expectations regarding patent attorneys’ work
-
Sponsored by Chang Tsi & PartnersRyan (Liangrui) Xu of Chang Tsi & Partners summarises key examination hurdles, landmark cases, and strategic opportunities for patent applicants using parameter-defined claims in China
-
Sponsored by Wanhuida Intellectual PropertyRevised examination guidelines and evolving technology have driven a surge in smart medicine patent filings and grants. Jie Zhao of Wanhuida Intellectual Property examines several examples of significance for foreign applicants
-
Sponsored by Berken IPEmilio Berkenwald of Berken IP says that although the move potentially eases prosecution, several issues – particularly concerning second medical use claims – remain
-
Sponsored by InspicosNils Byg Jørgensen of Inspicos says a recent EPO decision addresses the extent to which the description and drawings shall be consulted when interpreting claims under European Patent Convention provisions other than patentability
-
Sponsored by Remfry & SagarNeeraj Raina and Aditi Manhas of Remfry & Sagar analyse global patent trends in vehicle-to-everything technology as Indian filings and deployment momentum accelerate
